Although inhibitors of the VEGF pathway are substantially effective in reducing tumor vascularization, after treatment discontinuation the tumor vascular network is able to re-grow, acquiring overexpression of vascular growth factor receptors [36]. The gene discussed is VEGFA; the disease is neoplasm.